Literature DB >> 33407677

Acute encephalopathy in children with tuberous sclerosis complex.

Shingo Numoto1, Hirokazu Kurahashi2, Atsushi Sato3, Masaya Kubota4, Takashi Shiihara5, Tohru Okanishi6, Ryuta Tanaka7, Ichiro Kuki8, Tetsuhiro Fukuyama9, Mitsuru Kashiwagi10, Mitsuru Ikeno11, Kazuo Kubota12, Manami Akasaka13, Masakazu Mimaki14, Akihisa Okumura2.   

Abstract

OBJECTIVE: We examined the clinical manifestations of acute encephalopathy (AE) and identify risk factors for AE in children with tuberous sclerosis complex (TSC).
METHODS: The clinical data of 11 children with clinically diagnosed TSC associated with AE and 109 children with clinically diagnosed TSC alone aged 4 years or older were collected from 13 hospitals.
RESULTS: Of the 11 children with AE, 5 had histories of febrile seizures (FS), and all had histories of febrile status epilepticus (FSE). AE developed within 24 h after fever onset in all children with seizures lasting 30 min or longer. All children developed coma after seizure cessation. Head magnetic resonance imaging (MRI) revealed widespread abnormalities in the cerebral cortex, subcortical white matter, corpus callosum, basal ganglia, and thalamus. One child died; seven had severe neurological sequelae; and the other three, mild sequelae. Logistic regression analysis revealed that a history of FSE was correlated with the development of AE. SIGNIFICANCE: AE in children with TSC was characterized by sudden onset after fever, followed by coma, widespread brain edema evident on MRI, and poor outcomes. A history of FSE was a risk factor for the development of AE.

Entities:  

Keywords:  Clinical neurology history; Infantile spasms; MRI; Prognosis; Status epilepticus

Mesh:

Year:  2021        PMID: 33407677      PMCID: PMC7789140          DOI: 10.1186/s13023-020-01646-8

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  40 in total

Review 1.  Status epilepticus in adults.

Authors:  John P Betjemann; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2015-04-20       Impact factor: 44.182

Review 2.  Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.

Authors:  Francesco Brigo; Raffaele Nardone; Frediano Tezzon; Eugen Trinka
Journal:  Epilepsy Behav       Date:  2015-03-25       Impact factor: 2.937

3.  Total corpus callosotomy for epileptic spasms after acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in a case with tuberous sclerosis complex.

Authors:  Tohru Okanishi; Ayataka Fujimoto; Hirotaka Motoi; Sotaro Kanai; Mitsuyo Nishimura; Tomohiro Yamazoe; Atsushi Takagi; Takamichi Yamamoto; Hideo Enoki
Journal:  Brain Dev       Date:  2016-12-04       Impact factor: 1.961

4.  Febrile status epilepticus.

Authors:  J Maytal; S Shinnar
Journal:  Pediatrics       Date:  1990-10       Impact factor: 7.124

Review 5.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

6.  Tuberous sclerosis complex and the ketogenic diet.

Authors:  Eric H Kossoff; Elizabeth A Thiele; Heidi H Pfeifer; Jane R McGrogan; John M Freeman
Journal:  Epilepsia       Date:  2005-10       Impact factor: 5.864

7.  Hyperglycemia associated with seizure control in status epilepticus.

Authors:  Piyawan Chiewthanakul; Parinya Noppaklao; Kittisak Sawanyawisuth; Somsak Tiamkao
Journal:  Epilepsy Behav       Date:  2015-05-15       Impact factor: 2.937

8.  Acute encephalopathy in children with Dravet syndrome.

Authors:  Akihisa Okumura; Mitsugu Uematsu; George Imataka; Manabu Tanaka; Tohru Okanishi; Tetsuo Kubota; Akira Sudo; Jun Tohyama; Megumi Tsuji; Iori Ohmori; Misako Naiki; Ayako Hiraiwa-Sofue; Hitoshi Sato; Shinji Saitoh; Toshiaki Shimizu
Journal:  Epilepsia       Date:  2011-11-16       Impact factor: 5.864

9.  Generalised convulsive status epilepticus in Singapore: clinical outcomes and potential prognostic markers.

Authors:  Rahul Rathakrishnan; Novalia Purnama Sidik; Chan Yiong Huak; Einar P Wilder-Smith
Journal:  Seizure       Date:  2008-10-31       Impact factor: 3.184

10.  Combination of intravenous immunoglobulin and steroid pulse therapy improves outcomes of febrile refractory status epilepticus.

Authors:  Jainn-Jim Lin; Yu Wang; Shih-Yun Lan; Oi-Wa Chan; Shao-Hsuan Hsia; Min-Liang Chou; Po-Cheng Hung; Meng-Ying Hsieh; I-Jun Chou; Huei-Shyong Wang; Kuang-Lin Lin
Journal:  Epilepsy Res       Date:  2018-03-26       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.